biomedicina slovenica


"DOPAMINE" : 283

  1. Šet Vida; Šinkovec Jaka; Trošt Maja
    Dopaminski disregulacijski sindrom pri bolnikih s Parkinsonovo bolezijo
    [Dopamine dysregulation syndrome in Parkinson's disease patients]
    2017
  2. Turčin Arijana; Dolžan Vita; Porcelli Stefano; Serretti Alessandro; Kores-Plesničar Blanka
    Adenosine hypothesis of antipsychotic drugs revisited
    2016
  3. Terzič Tea; Kastelic Matej; Dolžan Vita; Kores-Plesničar Blanka
    Genetic polymorphisms in dopaminergic system and treatment-resistant schizophrenia
    2016
  4. Bogićević Sanja; Živin Marko
    Efficacy of potential atypical antipsychotic lek-8829 on behavioral effects in rat model of catalepsy and inhibition of amphetamine induced psychomotor stimulation
    [[Učinkovitost potencialnega atipičnega antipsihotika lek-8829 na vedenjske učinke na podganjih modelih katalepsije ter z amfetaminom povzročene psihomotorične stimulacije]]
    2015
  5. Tratnjek Larisa; Glavan Gordana; Višnjar Tanja; Živin Marko
    Up-regulation and axonal transport of synaptotagmin-IV in the direct pathway medium spiny neurons in hemi-parkinsonian rats induced by dopamine D1 receptor stimulation
    2016
  6. Dolžan Vita; Kores-Plesničar Blanka; Serretti Alessandro; Mandelli Laura; De Ronchi Diana; Olgiati Paolo; Zalar Bojan; Koprivšek Jure; Breskvar Katja
    Polymorphisms in dopamine receptor DRD1 and DRD2 genes and psychopathological and extrapyramidal symptoms in patients on long-term antipsychotic treatment
    2006
  7. Huang Yu-Ting; Georgiev Dejan; Foltynie Tom; Limousin Patricia; Speekenbrink Maarten; Jahanshahi Marjan
    Different effects of dopaminergic medication on perceptual decision-making in Parkinson's disease as a function of task difficulty and speed-accuracy instructions
    2015
  8. Batagelj Nevenka; Jensterle Sever Mojca; Dolžan Vita
    Genetska variabilnost dopaminergičnega sistema in izločanje inzulina ter metabolični odgovor na zdravljenje pri bolnicah s sindromom policističnih ovarijev
    2015
  9. Štemberger Nastja; Tratnjek Larisa; Živin Marko
    Dopaminergic modulation of synaptotagmin IV and substance P expression and characterization of striatal alterations during culture of organotypic whole brain slices from young rats
    2015
  10. Kapraljević Ana; Tratnjek Larisa; Živin Marko
    The effect of acute ibogaine treatment on the survival of dopaminergic neurons in organotypic nigrostriatal Co - cultures
    2015
  11. Tratnjek Larisa; Glavan Gordana; Živin Marko
    Dopaminergic modulation of synaptotagmin IV expression in animal model of Parkinson disease
    2015
  12. Bajrović Fajko; Jugović Domagoj; Milutinović Živin Aleksandra; Glavan Gordana; Tratnjek Larisa; Glišović Špela; Saghafi Mehdi M.; Živin Marko
    Synaptotagmin 4mRNA expression as an inducible indicator of dopaminergic hyperexcitation and of glutamatergic excitotoxicity
    2015
  13. Rodríguez José J.; Noristani Harun N.; Verkhratsky Alexei
    The serotonergic system in ageing and Alzheimer's disease
    2012
  14. L'Episcopo F.; Tirolo C.; Testa N.; Caniglia S.; Morale M. C.; Cossetti M. C.; D'Adamo Patrizia; Zardini E.; Andreoni L.; Ihekwaba A. E. C.
    Reactive astrocytes and Wnt/[beta]-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease
    2011
  15. Wilson Gabrielle R.; Sim Joe C. H.; McLean Catriona; Giannandrea Maila; Galea Charles A.; Riseley Jessica R.; Stephenson Sarah E. M.; Fitzpatrick Elizabeth; Haas Stefan A.; D'Adamo Patrizia
    Mutations in RAB39B cause X-linked intellectual disability and early-onset parkinson disease with [alpha]-synuclein pathology
    2014
  16. Locatelli Igor; Mrhar Aleš
    Odmerjanje zdravil za zdravljenje Alzheimerjeve in Parkinsonove bolezni
    [Dosage regimens of drugs used in the treatment of Alzheimer's and Parkinson's disease]
    2008
  17. Devjak Rok; Fon Tacer Klementina; Juvan Peter; Virant-Klun Irma; Rozman Damjana; Vrtačnik-Bokal Eda
    Cumulus cells gene expression profiling in terms of oocyte maturity in controlled ovarian hyperstimulation using GnRH agonist or GnRH antagonist
    2012
  18. Rojc Žan; Komel Radovan; Videtič Paska Alja
    Preiskava polimorfizmov v genu DRD2 pri žrtvah samomora
    2014
  19. Kubale Valentina; Blagotinšek Kaja; Pogačnik Azra; Vrecl Milka
    Vloga tretje znotrajcelične zanke pri regulaciji dolge oblike dopaminskega receptotja tipa 2 (D2L-R)
    2011
  20. Rubio-Agusti Ignacio; Kojović Maja; Edwards Mark J.; Murphy Elaine; Chandrashekar Hoskote S.; Lachmann Robin H.; Bhatia Kailash P.
    Atypical parkinsonism and cerebrotendinous xanthomatosis: report of a family with corticobasal syndrome and a literature review
    2012
  21. Bologna Matteo; Kojović Maja
    Interfacing basal ganglia models and Parkinson's disease phenomenology
    2012
  22. Grgurevič Neža; Strle Drago; Trifković Mario; Majdič Gregor
    Development of novel electrochemical biosensors for detection of neurotransmitters
    2013
  23. Tratnjek Larisa; Glavan Gordana; Živin Marko
    Dopaminergic modulation of striatalexpression of Synaptotagmin IV
    2013
  24. Moretti Rita; Torre Paola; Antonello Rodolfo M.; Vidus Rosin Marta; Esposito Francesca; Rubelli Furman Matej; Bellini Giuseppe
    Apathy
    2012
  25. Groznik Vida; Guid Matej; Sadikov Aleksander; Možina Martin; Georgiev Dejan; Kragelj Veronika; Ribarič Samo; Pirtošek Zvezdan; Bratko Ivan
    Elicitation of neurological knowledge with argument-based machine learning
    2013
  26. Siedlinski Mateuzs; Cho Michael H; Bakke Per; Košnik Mitja
    Genome-wide association study of smoking behaviours in patients with COPD
    2011
  27. Blagotinšek Kaja; Kubale Valentina; Pogačnik Azra; Vrecl Milka
    Identification of conserved motif in the third intracellular loop in dopamine receptor type 2 (D2L-R) related to intracellular retention of D2L-R
    2012
  28. Ribarič Samo
    The pharmacological properties and therapeutic use of apomorphine
    2012
  29. Jukić Tomislav; Rojc Bojan; Boben-Bardutzky Darja; Hafner Mateja; Ihan Alojz
    The use of a food supplementation with D-phenylalanine, L-glutamine and L-5-hydroxytriptophan in the alleviation of alcohol withdrawal symptoms
    2011
  30. Šubic Ana; Steblovnik Tjaša
    Vpliv kontinuirane dopaminergične stimulacije z ropinirolom na nemotorične simptome in kakovost življenja bolnikov s Parkinsonovo boleznijo
    2011
  31. Trošt M; Starovasnik-Žagavec B; Tomše P; Čuš A; Slodnjak I; Vodušek D; Pirtošek Z
    Cognitive and motor function correlation with brain activity in early Parkinson's disease and the effect of dopaminergic treatment
    2011
  32. Šubic Ana; Steblovnik Tjaša
    Vpliv kontinuirane dopaminergične stimulacije z ropinirolom na nemotorične simptome in kakovost življenja bolnikov s Parkinsonovo boleznijo
    2010
  33. Tomše Petra; Starovasnik-Žagavec Barbara; Grmek Marko; Slodnjak Ivan; Čuš Anja; Vodušek David B; Pirtošek Zvezdan; Trošt Maja
    Brain perfusion changes in Parkinson's disease: the effect of dopaminergic treatment
    2011
  34. Pirtošek Zvezdan
    Myths and realities of continuous dopaminergic stimulation
    2011
  35. Kapoon R; Pirtošek Z; Frankel JP; Stern GM; Lees AJ; Bottomley JM; Haran NS
    Treatment of Parkinson's disease with novel dopamine D2 agonist SK&F 101468
    1989
  36. Ostrovršnik Jaka; Cvirn Anina; Peterlin-Mašič Lucija
    Amfetamin in metamfetamin: mehanizem delovanja, učinki, zastrupitev in diagnostika
    [Amphetamine and methamphetamine: mechanism of action, effects, poisoning and diagnostics]
    2011
  37. Zaletel Marjan
    Zdravljenje fibromialgije
    [Treatment of fibromyalgia]
    2010
  38. Živin Marko
    Potential applications of dopamine D1 agonist and D2 antagonist LEK-8829
    2010
  39. Gregorič Kramberger Ljudmila; Štukovnik Vita; Čuš Anja; Repovš Grega; Tomše Petra; Pečarič-Meglič Nuška; Garaševič Zdenko; Jensterle Jože; Pirtošek Zvezdan
    Parkinson's disease dementia: clinical correlates of brain SPECT perfusion and treatment
    2010
  40. Kobal J; Švigelj V; Mesec A; Pogačnik T
    Unilateral spatial neglect after dopaminergic agonist treatment of patients with right hemisphere infarction
    1996
  41. Kobal Jan
    Early dopaminergic stimulation after an acute cerebral infarction
    1990
  42. Križaj David
    Mesopic state: cellular mechanisms involved in pre- and post-synaptic mixing of rod and cone signals
    2000
  43. Križaj David; Akopian Abram; Witkovsky Paul
    The effects of L-glutamate, AMPA, quisqualate, and kainate on retinal horizontal cells depend on adaptational state: implications for rod-cone interactions
    1994
  44. Križaj David; Gabriel Robert; Owen Geoffrey W; Witkovsky Paul
    Dopamine D2 receptor-mediated modulation of rod-cone coupling in the Xenopus retina
    1998
  45. Križaj David; Copenhagen David R
    Calcium regulation in photoreceptors
    2002
  46. Witkovsky Paul; Gabriel Robert; Križaj David
    Anatomical and neurochemical characterization of dopaminergic interplexiform processes in mouse and rat retinas
    2008
  47. Trošt M; Šubic A; Steblovnik T; Kirbiš M
    The effect of continuous dopaminergic stimulation with ropinirole on non-motor symptoms, quality of life and autonomic functions in Parkinson's disease patients
    2010
  48. Pal Robert
    Vpliv dopaminergične stimulacije na alternativno izrezovanje pre-mRNA sinaptotagmina 7 pri poskusnih podganah z normalno in s povečano dopaminergično odzivnostjo
    2009
  49. Georgiev Dejan; Danieli Aljoša; Ocepek Lidija; Novak Dominika; Zupančič-Križnar Nina; Trošt Maja; Pirtošek Zvezdan
    Othello syndrome in patients with Parkinson's disease
    2010
  50. Sinkovič Andreja
    Akutno srčno popuščanje pri bolnikih z akutnim srčnim infarktom - diagnoza, prognoza in zdravljenje
    [Acute heart failure in patients with acute myocardial infarction - diagnosis, prognosis and treatment]
    2009
  51. Mele Tina; Čarman-Kržan Marija; Jurič Damijana Mojca
    Regulatory role of monoamine neurotransmitters in astrocytic NT-3 synthesis
    2009
  52. Lainščak Mitja; Coletta Alison P; Sherwi Nasser; Cleland John G
    Clinical trials update from the Heart failure society of America meeting 2009: FAST, IMPROVE-HF, COACH galectin-3 substudy, HF-ACTION nuclear substudy, DAD-HF, and MARVEL-1
    2009
  53. Pirtošek Z; Flisar D
    Neuroprotection and dopamine agonists
    2004
  54. Pirtošek Zvezdan
    'Bad guys' among the antiparkinsonian drugs
    2009
  55. Trošt Maja; Dhawan Vijay; Feigin Andrew; Eidelberg David
    PET/SPECT
    2005
  56. Starovasnik Barbara; Repovš Grega; Čuš Anja; Foster Erin; Vodušek David B
    Prospective memory and dopaminergic therapy in early stage Parkinson's disease - a pilot study
    2009
  57. Steblovnik Tjaša; Šubic Ana; Ručna Veronika; Kirbiš Mojca; Trošt Maja
    The effect of continuous dopaminergic stimulation with ropinirole on non-motor symptoms and quality of life in patients with Parkinson's disease
    2009
  58. Kores-Plesničar Blanka; Dolžan Vita; Serretti Alessandro; Mandelli Laura; Zalar Bojan
    Polymorphisms in dopamine receptors genes and symptomatology in patients on maintenance antipsychotic therapy
    2009
  59. Korošec-Jagodič Helena; Jagodič Klemen; Pregelj Peter
    Obravnava bolnika z delirijem
    [Management of delirium]
    2009
  60. Zhai Weiguo; Jeong Hyunkyung; Cui Libin; Krainc Dimitri; Tjian Robert
    In vitro analysis of huntingtin-mediated transcriptional repression reveals multiple transcription factor targets
    2005
  61. Perdan Katja; Lipnik-Štangelj Metoda; Kržan Mojca
    The impact of astrocytes in the clearance of neurotransmitters by uptake and inactivation
    2009
  62. Novak D; Georgiev D; Zupančič KN
    Othello syndrome in four patients with Parkinson's disease
    2009
  63. Anonymous ;
    Old and new dopamine agonists in Parkinson's disease: a reapprasial. Final program and abstracts of te LIMPE seminar; 2009 Feb 26-28; Pisa
    2009
  64. Kobal Alfred Bogomir
    Možni vpliv živega srebra na patogenezo avtizma
    [Possible influence of mercury on pathogenesis of autism]
    2009
  65. Pregelj Peter
    Cirkadiani ritmi in depresija
    [Circadian rhytmicity and depression]
    2008
  66. Flisar Dušan; Puklavec Ludvik; Grmek Marko; Trošt Maja
    Slikanje SPECT dopaminskega prenašalca pri boleznih možganov
    [SPECT imaging of dopamine transporter in brain disorders]
    2008
  67. Glavan Gordana
    Intermittent l-DOPA treatment differentially alters synaptotagmin 4 and 7 gene expression in the striatum of hemiparkinsonian rats
    2008
  68. Kumperščak HG; Dolžan V; Videtič Alja; Plesničar BK
    Polymorphisms in genes encoding the serotonin and dopamine pathways in two sisters with metachromatic leukodystrophy
    2008
  69. Glavan Gordana; Živin Marko
    The influence of intermittent l-DOPA treatment on striatal molecular markers in hemiparkinsonian rats
    [Vpliv intermitentnega dajanja l-DOPA na striatne molekulske označevalce pri hemiparkinsonskih podganah]
    2008
  70. Trošt Maja; Grmek Marko; Puklavec Ludvik; Flisar Dušan
    Initial clinical experience with SPECT imaging of dopamine transporter in Slovenia
    2007
  71. Pal Robert; Živin Marko; Milutinovič Aleksandra; Jernej Branimir; Glavan Gordana
    Support to an association of the striatal synaptotagmin 7 mRNA up-regulation with dopaminergic hypersensitivuty
    2007
  72. Pal Robert; Živin Marko; Milutinovič Aleksandra; Jernej Branimir; Glavan Gordana
    Effect of apomorphine on striatal synaptotagmin 7 mRNA levels in reserpinized rats
    2007
  73. Kores-Plesničar Blanka
    Razlike v načinu delovanja antidepresivov
    [Differences in antidepressants' action]
    2007
  74. Dolžan Vita; Kores-Plesničar Blanka; Serretti Alessandro; Mandelli Laura; Zalar bojan; Koprivšek Jure; Breskvar Katja
    Polymorphisms in dopamine receptor DRD1 and DRD2 genes and psychopathological and extrapyramidal symptoms in patients on long-term antipsychotic treatment
    2007
  75. Lončar Darja
    Vpliv nevrotransmiterjev na sintezo nevrotrofičnega dejavnika možganskega izvora (BDNF) v astrocitih novorojenih podgan
    [Effect of neurotransmitters on brain-derived neurotrophic factor (BDNF) synthesis in neonatal rat astrocytes]
    2007
  76. Bresjanac Mara
    Vplivi celic in drugih sestavin aksinskega okolja na regeneracijo v perifernem in osrednjem živčevju
    1994
  77. Starovasnik B; Foster E; Repovš G; Vodušek DB; Hershey T
    Prospective memory in Parkinson's disease: possible impairment and the effect of dopaminergic therapy
    2006
  78. Starovasnik Barbara; Foster Erin; Repovš Grega; Vodušek David B; Hershey Tamara
    Prospektivni spomin v Parkinsonovi bolezni: prizadetost in vpliv dopaminergične terapije
    2006
  79. Milivojevič Nataša
    Vpliv ergolinskega derivata LEK-8829 na zasvojenost s kokainom pri podgani
    2006
  80. Kovačič Srečko; Bunc Gorazd; Ravnik Janez
    Correspondence between the time course of cerebral vasospasm and the level of cerebral dopamine-beta-hydroxylase in rabbits
    2006
  81. Videtič Alja; Pungerčič Galina
    Molekularna genetika samomorilnosti
    [Molecular genetics of suicide]
    2006
  82. Grad Anton; Kojovič Maja; Rot Uroš; Mofardin Serđo; Pirtošek Zvezdan
    Nevrološke zaplete hiponatremije lahko uspešno zdravimo z dopaminergičnimi pripravki
    2006
  83. Hočevar Samo B; Živin Marko; Milutinovič Aleksandra; Hawlina Marko; Hutton Emily; Ogorevc Božidar
    Simultaneous in vivo measurement of dopamine, serotonin and ascorbate in the striatum of experimental rats using voltammetric microprobe
    2006
  84. Jurič Damijana Mojca; Miklič Špela; Čarman-Kržan Marija
    Monoaminergic neuronal activity up-regulates BDNF synthesis in cultured neonatal rat astrocytes
    2006
  85. Sancin Kristjan; Vincek Katarina
    Vpliv holinergične stimulacije na motorične znake parkinsonizma: poskus z inhibitorjem acetilholinesteraze
    2005
  86. Bunc M; Pezdir T; Možina H; Možina M; Brvar M
    Butanol ingestion in an airpost hangar
    2006
  87. Flisar Dušan
    Sindrom nemirnih nog
    [Restless legs syndrome]
    2006
  88. Carbon M; Trošt M; Ghilardi MF; Eidelberg D
    Abnormal brain networks in primary torsion dystonia
    2004
  89. Glavan G; Živin M
    Differential expression of striatal synaptotagmin mRNA isoforms in hemiparkinsonian rats
    2005
  90. Rojc Bojan
    Imunski sistem in sindrom odvisnosti od alkohola
    2005
  91. Hočevar Samo; Živin Marko; Hawlina Marko; Milutinovič Aleksandra; Ogorevc Božidar
    In vivo application of overoxidized poly (1,2-phenylenediamine) coated carbon fiber microelectrode for stimultaneous measurement od dopamine, serotonin and ascorbate
    2005
  92. Yang Shi-Bing; Major Felix; Tietze Lutz F; Rupnik Marjan
    Block of delayed-rectifier potassium channels by reduced haloperidol and related compounds in mouse cortical neurons
    2005
  93. Pregelj Peter; Živin Mirko
    Nevrobiološki vidiki sindroma zasvojenosti s psihoaktivnimi snovmi
    2005
  94. Kovačič Srečko
    Subarahnoidno krvarenje i kronični arterijski vazospazam: kompjuterska analiza vazospazma i imunohistokemijske reaktivnosti centralnih noradrenergičkih povezanosti u kunića
    2004
  95. Trkaj Tinkara; Zbašnik Tina
    Nemotorični vidiki izklopa pri bolnikih s Parkinsonovo boleznijo
    2004
  96. Martinčič David
    Preprečevanje ekscitotoksične poškodbe striatuma poskusne podgane z isradipinom
    2004
  97. Bartolić A; Pirtošek Z; Rozman J; Ribarič S
    Postural stability of Parkinson's disease patients is improved by decreasing rigidity
    2005
  98. Dernovšek Mojca Z
    Dopaminski sistem in bipolarna motnja razpoloženja
    2005
  99. Rus-Makovec Maja
    Nevrobiološki mehanizmi odvisnosti od alkohola
    2004
  100. Starovasnik Barbara; Sever Alenka
    Motnje kognitivnih sposobnosti pri bolnikih s Parkinsonovo boleznijo
    [Cognitive impairments in patients with the Parkinsons disease]
    2004

1 101 201  



New search      Comments      Top of page Institute for Biostatistics and Medical Informatics